Interactive decision-support tool for risk-based radiation therapy plan comparison for hodgkin lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 2, 2014, Pages 433-445

  Brodin, N Patrik ^a   Maraldo, Maja V ^b   Aznar, Marianne C ^b,c   Vogelius, Ivan R ^b   Petersen, Peter M ^b   Bentzen, Søren M ^b,d   Specht, Lena ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; DECISION SUPPORT TOOLS; DIRECT VISUALIZATION; DOSE RESPONSE RELATIONSHIPS; METHODS AND MATERIALS; QUANTITATIVE ESTIMATION; RADIATION ONCOLOGISTS; VOLUMETRIC MODULATED ARC THERAPY;

DATA VISUALIZATION; DECISION SUPPORT SYSTEMS; DIGITAL STORAGE; ONCOLOGY; RADIOTHERAPY; RISK PERCEPTION; TISSUE; TISSUE ENGINEERING; VISUALIZATION;

TOOLS;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL DECISION MAKING; DOSE RESPONSE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RISK;

ADOLESCENT; DECISION SUPPORT TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HODGKIN DISEASE; HUMANS; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MODELS, STATISTICAL; ORGANS AT RISK; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RISK;

EID: 84891854829     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.10.028     Document Type: Article

References (47)

1. C. Herbst, F.A. Rehan, and C. Brillant et al. Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: A systematic review Haematologica 95 2010 494 500
2. L. Specht, and S. Rosenberg History of radiotherapy of Hodgkin's disease (now Hodgkin lymphoma) L. Specht, J. Yahalom, Radiotherapy for Hodgkin Lymphoma 2011 Springer Berlin 1 6
3. A. Engert, P. Schiller, and A. Josting et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3601 3608 (Pubitemid 46594052)
4. T. Girinsky, R. van der Maazen, and L. Specht et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277 (Pubitemid 44109907)
5. T. Girinsky, L. Specht, and M. Ghalibafian et al. The conundrum of Hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
6. Specht L, Yahalom J, Illidge T, et al. Modern radiotherapy for Hodgkin lymphoma - field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. 2013 Jun 18 [epub ahead of print]. pii: S0360-3016(13)00534-8. http://dx.doi.org/10.1016/j.ijrobp.2013.05. 005.
7. A. Engert, A. Plutschow, and H.T. Eich et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
8. M.V. Maraldo, M.C. Aznar, and I.R. Vogelius et al. Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma Int J Radiat Oncol Biol Phys 85 2013 1057 1065
9. L.B. Marks, E.D. Yorke, and A. Jackson et al. Use of normal tissue complication probability models in the clinic Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S10 S19
10. S.M. Bentzen, L.S. Constine, and J.O. Deasy et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S3 S9
11. V. Moiseenko, J. Wu, and A. Hovan et al. Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: An independent test of QUANTEC criteria using a prospectively collected dataset Int J Radiat Oncol Biol Phys 82 2012 1108 1114
12. A.C. Houweling, M.E. Philippens, and T. Dijkema et al. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients Int J Radiat Oncol Biol Phys 76 2010 1259 1265
13. I. Beetz, C. Schilstra, and F.R. Burlage et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors Radiother Oncol 105 2012 86 93
14. D.C. Bowers, D.E. McNeil, and Y. Liu et al. Stroke as a late treatment effect of Hodgkin's disease: A report from the Childhood Cancer Survivor Study J Clin Oncol 23 2005 6508 6515 (Pubitemid 46190242)
15. M.V. Maraldo, N.P. Brodin, and M.C. Aznar et al. Doses to carotid arteries after modern radiotherapy for Hodgkin lymphoma: Is stroke still a late effect of treatment? Int J Radiat Oncol Biol Phys 87 2013 297 303
16. M.L. de Bruin, L.D. Dorresteijn, and M.B. van't Veer et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma J Natl Cancer Inst 101 2009 928 937
17. P. Bhatti, L.H. Veiga, and C.M. Ronckers et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: An update from the Childhood Cancer Survivor Study Radiat Res 174 6 2010 741 752
18. I.R. Vogelius, S.M. Bentzen, and M.V. Maraldo et al. Risk factors for radiation-induced hypothyroidism: A literature-based meta-analysis Cancer 117 2011 5250 5260
19. M.L. Metzger, M.M. Hudson, and G.W. Somes et al. White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma J Clin Oncol 24 2006 1516 1521 (Pubitemid 46638772)
20. A. Kuten, R. Lubochitski, and G. Fishman et al. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy J Surg Oncol 61 1996 281 283 (Pubitemid 26117121)
21. M.J. Boomsma, H.P. Bijl, and M.E. Christianen et al. A prospective cohort study on radiation-induced hypothyroidism: Development of an NTCP model Int J Radiat Oncol Biol Phys 84 2012 e351 e356
22. E.M. van Leeuwen-Segarceanu, L.D. Dorresteijn, and S. Pillen et al. Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors Int J Radiat Oncol Biol Phys 82 2012 612 618
23. T. Rancati, C. Fiorino, and G. Sanguineti NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination Int J Radiat Oncol Biol Phys 75 2009 915 923
24. T. Rancati, M. Schwarz, and A.M. Allen et al. Radiation dose-volume effects in the larynx and pharynx Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S64 S69
25. E. Alevronta, A. Ahlberg, and P. Mavroidis et al. Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy Radiother Oncol 97 2010 54 59
26. J. Belderbos, W. Heemsbergen, and M. Hoogeman et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy Radiother Oncol 75 2005 157 164 (Pubitemid 40805244)
27. L.M. Morton, E.S. Gilbert, and P. Hall et al. Risk of treatment-related esophageal cancer among breast cancer survivors Ann Oncol 23 2012 3081 3091
28. L.B. Marks, S.M. Bentzen, and J.O. Deasy et al. Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S70 S76
29. E.X. Huang, A.J. Hope, and P.E. Lindsay et al. Heart irradiation as a risk factor for radiation pneumonitis Acta Oncol 50 2011 51 60
30. L.B. Travis, M. Gospodarowicz, and R.E. Curtis et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease J Natl Cancer Inst 94 2002 182 192 (Pubitemid 34162752)
31. N.P. Brodin, I.R. Vogelius, and M.V. Maraldo et al. Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale Cancer 118 2012 5432 5440
32. L.B. Travis, D.A. Hill, and G.M. Dores et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475 (Pubitemid 37430500)
33. G. Schellong, M. Riepenhausen, and C. Bruch et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies Pediatr Blood Cancer 55 2010 1145 1152
34. M.V. Maraldo, N.P. Brodin, and I.R. Vogelius et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma Int J Radiat Oncol Biol Phys 83 2012 1232 1237
35. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949 1955 (Pubitemid 23312611)
36. A.W. van den Belt-Dusebout, B.M. Aleman, and G. Besseling et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy Int J Radiat Oncol Biol Phys 75 2009 1420 1429
37. C.C. Pan, B.D. Kavanagh, and L.A. Dawson et al. Radiation-associated liver injury Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S94 S100
38. D.C. Hodgson, E.S. Gilbert, and G.M. Dores et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma J Clin Oncol 25 2007 1489 1497 (Pubitemid 46759253)
39. H.T. Eich, U. Haverkamp, and A. Engert et al. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma - a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group Int J Radiat Oncol Biol Phys 63 2005 860 865 (Pubitemid 41400076)
40. J.R. Cassady Clinical radiation nephropathy Int J Radiat Oncol Biol Phys 31 1995 1249 1256
41. Kornerup JS. Impact of OET in the Radiation Therapy Planning for Pediatric Cancer. Master's Thesis from dept. of Radiation Physics, Lund University, Sweden; 2012.
42. L.A. Dawson, and R.K. Ten Haken Partial volume tolerance of the liver to radiation Semin Radiat Oncol 15 2005 279 283 (Pubitemid 41377144)
43. A. Jackson, L.B. Marks, and Bentzen et al. The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S155 S160
44. S.M. Betnzen Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma Int J Radiat Biol 61 1992 417 423
45. Special considerations regarding absorbed-dose and dose-volume prescribing and reporting in IMRT J ICRU 10 2010 27 40
46. P. Lambin, R.G. van Stiphout, and M.H. Starmans et al. Predicting outcomes in radiation oncology - multifactorial decision support systems Nat Rev Clin Oncol 10 2012 27 40
47. A. Niemerko, M. Urie, and M. Gotein Optimization of 3D radiation therapy with both physical and biological endpoints and constraints Int J Radiat Oncol Biol Phys 23 1992 99 108